Insulin resistance syndrome and glucose dysregulation in the elderly.
The incidence of insulin resistance in the geriatric population is growing as this population grows. The management of hyperglycemia and its associated risk factors depends on an expanding understanding of the underlying pathophysiology and progression of disease and of the currently available and future therapeutics, which are continually evolving. There is a major need for studies in the long-term care setting to determine the appropriate standard of care in prevention and treatment of metabolic dysregulation.